Wall Street analysts believe that a more cautious approach to manufacturing, study enrollment and side effect management could help developers avoid future safety hazards.
The company is now hoping for an affirmative answer on its application after an unusually turbulent year dealing with U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results